What's in TriHealth Inc.'s pipeline?

TriHealth Inc. has 12 drugs in our index: 5 marketed, 0 filed, 3 in Phase 3, 0 in Phase 2, 3 in Phase 1.

Which companies overlap with TriHealth Inc.'s portfolio?

Top competitors by shared drug class: Kasr El Aini Hospital, Ain Shams University, Bozyaka Training and Research Hospital, Hospital General Universitario Elche, University Health Network, Toronto.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/trihealth-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

TriHealth Inc. — Portfolio Competitive Intelligence Brief

TriHealth Inc. pipeline: 5 marketed, 0 filed, 3 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

5 marketed 0 filed 3 Phase 3 0 Phase 2 3 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Lidocaine alone	Lidocaine alone	marketed	Local anesthetic	Voltage-gated sodium channels	Anesthesia / Pain Management
local infiltration of liposomal bupivacaine	local infiltration of liposomal bupivacaine	marketed	Local anesthetic (amide class)	Voltage-gated sodium channels	Anesthesia / Pain Management
Lidocaine Ropivacaine	Lidocaine Ropivacaine	marketed	Local anesthetic (amide class)	Voltage-gated sodium channels	Anesthesia
Estradiol 0.01% Vag Cream	Estradiol 0.01% Vag Cream	marketed	Estrogen receptor agonist	Estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ)	Gynecology / Women's Health
Saline-only catheter flush	Saline-only catheter flush	marketed			Medical Device/Vascular Access
Vaginal conjugated estrogen cream 1.0gm	Vaginal conjugated estrogen cream 1.0gm	phase 3	estrogen replacement therapy		Women's Health
Bupivacaine-Meloxicam	Bupivacaine-Meloxicam	phase 3	Local anesthetic + NSAID combination	Voltage-gated sodium channels (bupivacaine); COX-1/COX-2 (meloxicam)	Pain Management / Anesthesia
Vaginal conjugated estrogen cream 0.5gm	Vaginal conjugated estrogen cream 0.5gm	phase 3	estrogen replacement therapy		Women's Health

Therapeutic area mix

Anesthesia / Pain Management · 2
Women's Health · 2
Anesthesia · 1
Medical Device/Vascular Access · 1
Pain Management / Anesthesia · 1
Gynecology / Women's Health · 1
Gastroenterology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Kasr El Aini Hospital · 2 shared drug classes
Ain Shams University · 2 shared drug classes
Bozyaka Training and Research Hospital · 2 shared drug classes
Hospital General Universitario Elche · 2 shared drug classes
University Health Network, Toronto · 2 shared drug classes
Aultman Health Foundation · 1 shared drug class
Atlantic Health System · 1 shared drug class
Ain Shams Maternity Hospital · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for TriHealth Inc.:

Cite this brief

Drug Landscape (2026). TriHealth Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/trihealth-inc. Accessed 2026-05-16.